These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2738179)

  • 1. Isotretinoin embryopathy--a continuing problem.
    Rappaport EB; Knapp M
    J Clin Pharmacol; 1989 May; 29(5):463-5. PubMed ID: 2738179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Face-to-face: isotretinoin use and pregnancy outcome.
    Tırmıkçıoğlu Z; Tatlıparmak A
    Int J Dermatol; 2024 Feb; 63(2):232-238. PubMed ID: 38095245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin and pregnancy.
    Stern RS; Rosa F; Baum C
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):851-4. PubMed ID: 6233342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of isotretinoin embryopathy with bilateral anotia and Taussig-Bing malformation.
    Ceviz N; Ozkan B; Eren S; Ors R; Olguntürk R
    Turk J Pediatr; 2000; 42(3):239-41. PubMed ID: 11105626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid embryopathy.
    Lammer EJ; Chen DT; Hoar RM; Agnish ND; Benke PJ; Braun JT; Curry CJ; Fernhoff PM; Grix AW; Lott IT
    N Engl J Med; 1985 Oct; 313(14):837-41. PubMed ID: 3162101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital neuroblastoma in a neonate with isotretinoin embryopathy.
    Aguilar S; Louis C; Hicks J; Zage P; Russell H
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e75-7. PubMed ID: 23652876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isotretinoin embryopathy: An entity that can be avoided].
    Cammarata-Scalisi F; Nieves D; Avendaño A; Lacruz-Rengel MA; Alviárez K; Dávila F; Yavuz I; Callea M
    Arch Argent Pediatr; 2018 Apr; 116(2):e303-e307. PubMed ID: 29557621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.
    Autret-Leca E; Kreft-Jais C; Elefant E; Cissoko H; Darrouzain F; Grimaldi-Bensouda L; Attia S; Jonville-Béra AP
    Drug Saf; 2010 Aug; 33(8):659-65. PubMed ID: 20635824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isotretinoin embryopathy with microtia-anotia and congenital heart disease: case report].
    Pachajoa H; Ordoñez A
    Arch Argent Pediatr; 2012; 110(3):e47-9. PubMed ID: 22760759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety issues in isotretinoin therapy.
    Hanson N; Leachman S
    Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinoic acid embryopathy].
    Harada M
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):86-7. PubMed ID: 11057153
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance.
    Lynberg MC; Khoury MJ; Lammer EJ; Waller KO; Cordero JF; Erickson JD
    Teratology; 1990 Nov; 42(5):513-9. PubMed ID: 2278026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of isotretinoin exposure during pregnancy.
    Dai WS; LaBraico JM; Stern RS
    J Am Acad Dermatol; 1992 Apr; 26(4):599-606. PubMed ID: 1597546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of pregnancy after discontinuation of isotretinoin.
    Dai WS; Hsu MA; Itri LM
    Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limb reduction defects in humans associated with prenatal isotretinoin exposure.
    Rizzo R; Lammer EJ; Parano E; Pavone L; Argyle JC
    Teratology; 1991 Dec; 44(6):599-604. PubMed ID: 1805430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.